Black Rock Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 42,010,826 shares of DNA stock, worth $397 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,010,826

Previous 72,862,092 42.34%

Holding current value

$397 Million

Previous $84.5 Million 83.6%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $8.64 Million - $35.8 Million	-30,851,266 Reduced 42.34%	42,010,826 $13.9 Million
Q1 2024 May 10, 2024	BUY	$1.06 - $1.67 $71,259 - $112,267	67,226 Added 0.09%	72,862,092 $84.5 Million
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $120,454 - $171,122	95,599 Added 0.13%	72,794,866 $123 Million
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $7.24 Million - $11.4 Million	4,496,435 Added 6.59%	72,699,267 $132 Million
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $20 Million - $34.2 Million	17,538,752 Added 34.62%	68,202,832 $127 Million
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $4.33 Million - $7.9 Million	3,608,124 Added 7.67%	50,664,080 $67.4 Million
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $26 Million - $56.2 Million	15,963,150 Added 51.34%	47,055,956 $79.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $920,133 - $4.71 Million	-1,260,457 Reduced 3.9%	31,092,806 $97 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $36.1 Million - $68.9 Million	16,399,997 Added 102.8%	32,353,263 $77 Million
Q1 2022 May 12, 2022	SELL	$2.83 - $8.69 $1.14 Million - $3.5 Million	-402,842 Reduced 2.46%	15,953,266 $64.3 Million
Q4 2021 Feb 10, 2022	BUY	$8.31 - $14.92 $136 Million - $244 Million	16,356,108 New	16,356,108 $136 Million

Others Institutions Holding DNA

# of Institutions

Shares Held

48.1M

Call Options Held

Put Options Held

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account